Adrian Adams

Companies

• Akebia Therapeutics, Inc.Board member Dec 13, 2018 to now¹
• AcelRx Pharmaceuticals (United States)Board member Feb 13, 2013 to now²
• Impel Neuropharma (United States)Board member Apr 22, 2021 to Feb 16, 2023³
• Impel Neuropharma (United States)Chief executive officer Apr 22, 2021 to Feb 16, 2023³
• Impel Neuropharma (United States)President Apr 22, 2021 to Feb 16, 2023³
• Amylin PharmaceuticalsBoard member Oct 31, 2007 to Aug 10, 2012⁴
• Neurocrine BiosciencesBoard member Jun 30, 2006 to Jun 30, 2006⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAkebia Therapeutics, Inc. AKBA236,200 shares⁶$166.7K at $0.71Jun 17, 2026
• AcelRx Pharmaceuticals (United States) TLPH22,709 shares⁷$24.3K at $1.07Jun 22, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 22, 2026Granted 5,100 shares of AcelRx Pharmaceuticals (United States)⁷
• Jun 17, 2026Granted 35,700 shares of Akebia Therapeutics, Inc.⁶
• Oct 23, 2025Granted 4,267 shares of AcelRx Pharmaceuticals (United States)⁸
• Jun 10, 2025Granted 35,700 shares of Akebia Therapeutics, Inc.⁹
• Jun 24, 2024Granted 2,174 shares of AcelRx Pharmaceuticals (United States)¹⁰
• Jun 6, 2024Granted 30,000 shares of Akebia Therapeutics, Inc.¹¹
• Oct 10, 2023Granted 581 shares of AcelRx Pharmaceuticals (United States)¹²
• Jun 6, 2023Granted 30,000 shares of Akebia Therapeutics, Inc.¹³
• Jul 15, 2022Granted 15,500 shares of AcelRx Pharmaceuticals (United States)¹⁴
• Jun 8, 2022Granted 13,700 shares of Akebia Therapeutics, Inc.¹⁵